| 前收盘价格 | 2.23 |
| 收盘价格 | 2.40 |
| 成交量 | 782,042 |
| 平均成交量 (3个月) | 161,419 |
| 市值 | 35,862,996 |
| 市盈率 (P/E TTM) | 0.372 |
| 价格/销量 (P/S) | 1.79 |
| 股市价格/股市净资产 (P/B) | 2.32 |
| 52周波幅 | |
| 利润日期 | 12 Feb 2026 |
| 营业毛利率 | -215.24% |
| 营业利益率 (TTM) | -242.68% |
| 稀释每股收益 (EPS TTM) | -0.220 |
| 季度收入增长率 (YOY) | 18.30% |
| 总债务/股东权益 (D/E MRQ) | 16.10% |
| 流动比率 (MRQ) | 3.80 |
| 营业现金流 (OCF TTM) | -29.08 M |
| 杠杆自由现金流 (LFCF TTM) | -7.41 M |
| 资产报酬率 (ROA TTM) | -49.03% |
| 股东权益报酬率 (ROE TTM) | -93.86% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 混合的 |
| Biotechnology (全球的) | 混合的 | 混合的 | |
| 股票 | Veru Inc. | 看涨 | 看涨 |
AIStockmoo 评分
0.3
| 分析师共识 | 3.5 |
| 内部交易活动 | NA |
| 价格波动 | 0.5 |
| 技术平均移动指标 | -2.5 |
| 技术振荡指标 | -0.5 |
| 平均 | 0.25 |
|
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 14.19% |
| 机构持股比例 | 33.43% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Sheets Smith Investment Management | 30 Sep 2025 | 322,084 |
| Oppenheimer & Co Inc | 30 Sep 2025 | 192,168 |
| Pvg Asset Management Corp | 30 Jun 2025 | 164,737 |
| Summit Financial, Llc | 30 Sep 2025 | 163,852 |
| Ikarian Capital, Llc | 30 Sep 2025 | 142,523 |
| Envestnet Asset Management Inc | 30 Sep 2025 | 76,674 |
| Choreo, Llc | 30 Sep 2025 | 75,468 |
| 52周波幅 | ||
| 中 | 25.00 (1,018.87%) | |
| 总计 | 1 购买 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Canaccord Genuity | 18 Dec 2025 | 25.00 (1,018.87%) | 购买 | 2.23 |
该时间范围内无数据。
| 5年平均股息收益率 | 0.00% |
| 除息日 | 公告日期 | 支付日期 | 详情 |
|---|---|---|---|
| 28 Apr 2014 | 24 Mar 2014 | 07 May 2014 | 0.07 现金 |
| 27 Jan 2014 | 16 Dec 2013 | 05 Feb 2014 | 0.07 现金 |
| 28 Oct 2013 | 03 Oct 2013 | 06 Nov 2013 | 0.07 现金 |
| 29 Jul 2013 | 15 Jul 2013 | 07 Aug 2013 | 0.07 现金 |
| 28 Jan 2013 | 03 Jan 2013 | 06 Feb 2013 | 0.06 现金 |
每年股息收益率
| 年份 | 每年总股息 ($) | 频率/年份 | 收益率 % |
|---|---|---|---|
| 2014 | 0.140 | 2 | 3.57 |
| 2013 | 0.200 | 3 | 2.35 |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合